Commission Implementing Regulation (EU) 2025/103 of 22 January 2025 approving the active substance Betabaculovirus phoperculellae as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
195/2025
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2025/103 of 22 January 2025 approving the active substance Betabaculovirus phoperculellae as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011
Durchführungsverordnung (EU) 2025/103 der Kommission vom 22. Januar 2025 zur Genehmigung des Wirkstoffs Betabaculovirus phoperculellae als Wirkstoff mit geringem Risiko gemäß der Verordnung (EG) Nr. 1107/2009 des Europäischen Parlaments und des Rates und zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 der Kommission
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.